drugset / Trial / NCT02673164

Stem Cell Therapy in IschEmic Non-treatable Cardiac Disease

NCT02673164 ↗

Phase 2 Completed 133 enrolled JKastrup European Union · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of the SCIENCE study is, in an international multicentre double-blind placebo-controlled study, to investigate efficacy of direct intra-myocardial injection of 100 mio. allogeneic Cardiology Stem Cell Centre\_adipose derived stem cells (CSCC\_ASCs) in patients with reduced left ventricular Ejection Fraction (EF) (≤45%) and heart failure.

Timeline

Start
2017-01
Primary completion
2020-12
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator CSCC_ASC Cell therapy 1e+08 cells Other

Indications